Bolt Biotherapeutics Inc
(BOLT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 1,275 | 5,274 | 2,089 | 2,528 | 1,433 |
| Gross Profit | 1,275 | 5,274 | 2,089 | 2,528 | 1,433 |
| Operating Expenses | 23,872 | 22,366 | 21,855 | 20,711 | 21,265 |
| Operating Income | -22,597 | -17,092 | -19,766 | -18,183 | -19,832 |
| Other Income | 1,402 | 6,281 | 1,863 | 1,926 | 1,775 |
| Pre-tax Income | -21,195 | -10,811 | -17,903 | -16,257 | -18,057 |
| Net Income Continuous | -21,195 | -10,811 | -17,903 | -16,257 | -18,057 |
| Net Income | $-21,195 | $-10,811 | $-17,903 | $-16,257 | $-18,057 |
| EPS Basic Total Ops | -11.12 | -5.60 | -9.40 | -8.60 | -9.60 |
| EPS Basic Continuous Ops | -11.12 | -5.68 | -9.44 | -8.59 | -9.57 |
| EPS Diluted Total Ops | -11.12 | -5.60 | -9.40 | -8.60 | -9.60 |
| EPS Diluted Continuous Ops | -11.12 | -5.68 | -9.44 | -8.59 | -9.57 |
| EPS Diluted Before Non-Recurring Items | -11.20 | -5.60 | -9.40 | N/A | N/A |
| EBITDA(a) | $-22,931 | $-17,667 | $-20,493 | $-19,056 | $-20,486 |